Karlsson I - Search Results

1

Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.

Blennow K, Wallin A, Gottfries CG, Lekman A, Karlsson I, Skoog I, Svennerholm L. Blennow K, et al. Among authors: karlsson i. Neurobiol Aging. 1992 Jan-Feb;13(1):107-13. doi: 10.1016/0197-4580(92)90017-r. Neurobiol Aging. 1992. PMID: 1371850

2

Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.

Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, Långström G, Skoog I, Svennerholm L, Wikkelsö C. Blennow K, et al. Among authors: karlsson i. Eur Neurol. 1993;33(2):129-33. doi: 10.1159/000116919. Eur Neurol. 1993. PMID: 8467819

3

Increased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease.

Karlsson JO, Blennow K, Janson I, Blomgren K, Karlsson I, Regland B, Wallin A, Gottfries CG. Karlsson JO, et al. Among authors: karlsson i. Neurobiol Aging. 1995 Nov-Dec;16(6):901-6. doi: 10.1016/0197-4580(95)02004-7. Neurobiol Aging. 1995. PMID: 8622780

4

Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.

Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Karlsson I, Månsson JE, Svennerholm L. Blennow K, et al. Among authors: karlsson i. Arch Neurol. 1991 Oct;48(10):1032-5. doi: 10.1001/archneur.1991.00530220048018. Arch Neurol. 1991. PMID: 1929894

5

Intrathecal synthesis of immunoglobulins in patients with Alzheimer's disease.

Blennow K, Wallin A, Fredman P, Gottfries CG, Karlsson I, Svennerholm L. Blennow K, et al. Among authors: karlsson i. Eur Neuropsychopharmacol. 1990 Nov;1(1):79-81. doi: 10.1016/0924-977x(90)90017-5. Eur Neuropsychopharmacol. 1990. PMID: 2136219

6

Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors.

Blennow K, Wallin A, Fredman P, Karlsson I, Gottfries CG, Svennerholm L. Blennow K, et al. Among authors: karlsson i. Acta Neurol Scand. 1990 Apr;81(4):323-6. doi: 10.1111/j.1600-0404.1990.tb01563.x. Acta Neurol Scand. 1990. PMID: 2360400

7

Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue.

Nilsson E, Alafuzoff I, Blennow K, Blomgren K, Hall CM, Janson I, Karlsson I, Wallin A, Gottfries CG, Karlsson JO. Nilsson E, et al. Among authors: karlsson i, karlsson jo. Neurobiol Aging. 1990 Jul-Aug;11(4):425-31. doi: 10.1016/0197-4580(90)90009-o. Neurobiol Aging. 1990. PMID: 2381502

8

Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.

Bråne G, Gottfries CG, Blennow K, Karlsson I, Lekman A, Parnetti L, Svennerholm L, Wallin A. Bråne G, et al. Among authors: karlsson i. Alzheimer Dis Assoc Disord. 1989 Fall;3(3):148-56. doi: 10.1097/00002093-198903030-00004. Alzheimer Dis Assoc Disord. 1989. PMID: 2477044

9

Decreased myelin lipids in Alzheimer's disease and vascular dementia.

Wallin A, Gottfries CG, Karlsson I, Svennerholm L. Wallin A, et al. Among authors: karlsson i. Acta Neurol Scand. 1989 Oct;80(4):319-23. doi: 10.1111/j.1600-0404.1989.tb03886.x. Acta Neurol Scand. 1989. PMID: 2816288

10

Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age.

Blennow K, Wallin A, Gottfries CG, Karlsson I, Månsson JE, Skoog I, Wikkelsö C, Svennerholm L. Blennow K, et al. Among authors: karlsson i. Eur Neuropsychopharmacol. 1993 Mar;3(1):55-61. doi: 10.1016/0924-977x(93)90295-w. Eur Neuropsychopharmacol. 1993. PMID: 7682460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters